Intravenous thrombolysis guided by a telemedicine consultation system for acute ischaemic stroke patients in China: The protocol of a multicentre historically controlled study

BMJ Open

Volumn 5, Issue 5, 2015, Pages

  Yuan, Ziwen ^a   Wang, Bo ^b   Li, Feijiang ^b   Wang, Jing ^a   Zhi, Jin ^a   Luo, Erping ^b   Liu, Zhirong ^a   Zhao, Gang ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; UROKINASE; FIBRINOLYTIC AGENT; PLAT PROTEIN, HUMAN; TISSUE PLASMINOGEN ACTIVATOR;

ARTICLE; AUDIOVISUAL EQUIPMENT; BLOOD CLOT LYSIS; BRAIN ISCHEMIA; CHINA; CLINICAL PROTOCOL; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; MEDICAL DECISION MAKING; MULTICENTER STUDY; OUTCOME ASSESSMENT; PATIENT SELECTION; TELECONSULTATION; TELEMEDICINE; BLOOD; CLINICAL TRIAL; EPIDEMIOLOGY; EVALUATION STUDY; FEMALE; FIBRINOLYTIC THERAPY; INTRAVENOUS DRUG ADMINISTRATION; MALE; PROCEDURES; STROKE; TREATMENT OUTCOME; VERY ELDERLY;

ADMINISTRATION, INTRAVENOUS; AGED, 80 AND OVER; CHINA; FEMALE; FIBRINOLYTIC AGENTS; HISTORICALLY CONTROLLED STUDY; HUMANS; MALE; REMOTE CONSULTATION; STROKE; TELEMEDICINE; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME;

EID: 84930221949     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2014-006704     Document Type: Article

References (32)

1. Hacke W, Donnan G, Fieschi C, et al. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet 2004;363:768-74.
2. Hacke W, Kaste M, Bluhmki E, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 2008;359:1317-29.
3. Lansberg MG, Schrooten M, Bluhmki E, et al. Treatment time-specific number needed to treat estimates for tissue plasminogen activator therapy in acute stroke based on shifts over the entire range of the modified Rankin Scale. Stroke 2009;40:2079-84.
4. Sandercock P, Wardlaw JM, Lindley RI, et al. The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial. Lancet 2012;379:2352-63.
5. Jauch EC, Saver JL, Adams HJ, et al. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2013;44:870-947.
6. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333:1581-7.
7. Liu M, Zhang S, Rao M, et al. 2010 Chinese guidelines for the diagnosis and treatment of patients with acute ischemic stroke. Chin J Front Med Sci 2010;2:50-9.
8. The Ninth 5-year National Project Collaboration. Intravenous thrombolysis with urokinase for acute cerebral infarctions (within 6 h from symptom onset). J Apoplexy Nerv Dis 2001;18:259-61.
9. The Ninth 5-year National Project Collaboration. Intravenous thrombolysis with urokinase for acute cerebral infarctions (within 6 h from symptom onset). Chin J Neurol 2002;4:210-13.
10. Bi Q, Zhang Z, Zhang WW, et al. Study on prehospital time and influencing factors of stroke patients in 15 Chinese cities. Zhonghua Liu Xing Bing Xue Za Zhi 2006;27:996-9.
11. Wang Y, Liao X, Zhao X, et al. Using recombinant tissue plasminogen activator to treat acute ischemic stroke in China: analysis of the results from the Chinese National Stroke Registry (CNSR). Stroke 2011;42:1658-64.
12. Wang Y, Wu D, Zhao X, et al. Hospital resources for urokinase/recombinant tissue-type plasminogen activator therapy for acute stroke in Beijing. Surg Neurol 2009;72(Suppl 1):S2-7.
13. Hess DC, Audebert HJ. The history and future of telestroke. Nat Rev Neurol 2013;9:340-50.
14. Silva GS, Farrell S, Shandra E, et al. The status of telestroke in the United States: a survey of currently active stroke telemedicine programs. Stroke 2012;43:2078-85.
15. Chalouhi N, Dressler JA, Kunkel ES, et al. Intravenous tissue plasminogen activator administration in community hospitals facilitated by telestroke service. Neurosurgery 2013;73:667-71, 671-2.
16. Muller-Barna P, Schwamm LH, Haberl RL. Telestroke increases use of acute stroke therapy. Curr Opin Neurol 2012;25:5-10.
17. Audebert H. Telestroke: effective networking. Lancet Neurol 2006;5:279-82.
18. Audebert HJ, Boy S, Jankovits R, et al. Is mobile teleconsulting equivalent to hospital-based telestroke services? Stroke 2008;39:3427-30.
19. Audebert HJ, Kukla C, Vatankhah B, et al. Comparison of tissue plasminogen activator administration management between Telestroke Network hospitals and academic stroke centers: the Telemedical Pilot Project for Integrative Stroke Care in Bavaria/Germany. Stroke 2006;37:1822-7.
20. Audebert HJ, Kukla C, Clarmann VCS, et al. Telemedicine for safe and extended use of thrombolysis in stroke: the Telemedic Pilot Project for Integrative Stroke Care (TEMPiS) in Bavaria. Stroke 2005;36:287-91.
21. Pervez MA, Silva G, Masrur S, et al. Remote supervision of IV-tPA for acute ischemic stroke by telemedicine or telephone before transfer to a regional stroke center is feasible and safe. Stroke 2010;41:e18-24.
22. Sairanen T, Soinila S, Nikkanen M, et al. Two years of Finnish Telestroke: thrombolysis at spokes equal to that at the hub. Neurology 2011;76:1145-52.
23. LaMonte MP, Bahouth MN, Xiao Y, et al. Outcomes from a comprehensive stroke telemedicine program. Telemed J E Health 2008;14:339-44.
24. Pedragosa A, Alvarez-Sabin J, Molina CA, et al. Impact of a telemedicine system on acute stroke care in a community hospital. J Telemed Telecare 2009;15:260-3.
25. Dharmasaroja PA, Muengtaweepongsa S, Kommarkg U. Implementation of telemedicine and stroke network in thrombolytic administration: comparison between walk-in and referred patients. Neurocrit Care 2010;13:62-6.
26. Goldstein LB, Jones MR, Matchar DB, et al. Improving the reliability of stroke subgroup classification using the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) criteria. Stroke 2001;32:1091-8.
27. van Swieten JC, Koudstaal PJ, Visser MC, et al. Interobserver agreement for the assessment of handicap in stroke patients. Stroke 1988;19:604-7.
28. Brott T, Adams HJ, Olinger CP, et al. Measurements of acute cerebral infarction: a clinical examination scale. Stroke 1989;20:864-70.
29. Barber PA, Demchuk AM, Zhang J, et al. Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. ASPECTS Study Group. Alberta Stroke Programme Early CT Score. Lancet 2000;355:1670-4.
30. Tei H, Uchiyama S, Usui T. Predictors of good prognosis in total anterior circulation infarction within 6 h after onset under conventional therapy. Acta Neurol Scand 2006;113:301-6.
31. Mitchell JR, Sharma P, Modi J, et al. A smartphone client-server teleradiology system for primary diagnosis of acute stroke. J Med Internet Res 2011;13:e31.
32. Demaerschalk BM, Vegunta S, Vargas BB, et al. Reliability of real-time video smartphone for assessing National Institutes of Health Stroke Scale scores in acute stroke patients. Stroke 2012;43:3271-7.